Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 24Unknown 5Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia 4Recurrence 2Lymphoma 2Leukemia, Monocytic, Acute 2Congenital Abnormalities 2Thrombocythemia, Essential 1Sarcoma, Kaposi 1Sarcoma 1Primary Myelofibrosis 1Polycythemia Vera 1Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Hematologic Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

Cytarabine 8Mitoxantrone 5Peripheral Blood Stem Cell Transplantation 3Idarubicin 3Filgrastim 3Etoposide 3Busulfan 3fludarabine phosphate 2Vorinostat 2Tacrolimus 2Methotrexate 2Decitabine 2Cyclophosphamide 2Bortezomib 2tanespimycin 1ixazomib 1entinostat 1eltrombopag 1choline magnesium trisalicylate 1alvocidib 1Sorafenib 1Proteasome Inhibitors 1Pravastatin 1Mycophenolic Acid 1Metformin 1Lenalidomide 1Immunologic Techniques 1Homoharringtonine 1Granulocyte Colony-Stimulating Factor 1Gemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myelomonocytic, Acute × Daunorubicin × Clear all
NCT00814164 2016-08-17

Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 2 Terminated
21 enrolled 8 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡